Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis
Review
OA: gold
CC0
⤵ 6 in-corpus citations
AI-generated summary
Anti-laminin-1 antibodies, found in women with recurrent pregnancy loss and endometriosis-associated infertility, react with laminin-1 chains and may contribute to reproductive failure.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Laminin-1 is a major component and multifunctional glycoprotein of basement membranes that consists of three different subunits, alpha1, beta1 and gamma11 chains. It is the earliest synthesized network-forming protein during embryogenesis and plays an important role in embryonic development, embryonic implantation and placentation. We have recently shown that IgG anti-laminin-1 antibodies were significantly associated with recurrent first-trimester miscarriages and with subsequent pregnancy outcome. Interestingly, these antibodies were also observed in patients with endometriosis-associated infertility but not in patients with other causes of infertility, including tubal factors, hormonal and uterine abnormalities. Laminin-alpha1, -beta1 and -gamma1 mRNAs have been detected in 90% of endometriotic lesions and all laminin-alpha1, -beta1 and -gamma1 chains were localized in the basement membranes of glandular epithelium in endometriotic peritoneal lesions. Western blot analysis showed that anti-laminin-1 antibodies from those patients reacted with all laminin-1's chains. ELISA also confirmed that one of the target epitopes for these antibodies was located in a particular region of the laminin-1 molecule, i.e. the carboxyl-terminal globular G domain of alpha1 chain. IgM monoclonal anti-laminin-1 autoantibody, that we recently established, also recognized the G domain. Anti-laminin-1 antibodies from mice immunized with "mouse" laminin-1, caused a higher fetal resorption rate with lower embryonic and placental weights. Thus, anti-laminin-1 antibodies may be important in development of autoimmune-mediated reproductive failures and the assessment of the antibodies may provide a novel non-invasive diagnosis of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (23)
- An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients via openalex
- Autoimmunity in endometriosis: relevance to infertility via openalex
- Autoimmunity to endometrium and ovary in endometriosis via openalex
- Autoimmunity to Endometrium and Ovary in Endometriosis via openalex
- Levels of antibodies to transferrin and alpha 2-HS glycoprotein in women with and without endometriosis via openalex
- W2025361420 via openalex
- W2030227542 via openalex
- W2051053458 via openalex
- W2055628031 via openalex
- W2057504287 via openalex
- W2089747751 via openalex
- W2093514870 via openalex
- W2110188006 via openalex
- W2143987989 via openalex
- W2144345918 via openalex
- W2152927880 via openalex
- W2182870479 via openalex
- W2403747902 via openalex
- W6673689116 via openalex
- W204827399 via openalex
- W1523307634 via openalex
- W1577029525 via openalex
- W1973814917 via openalex
Cited by (6)
- Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool? 2021
- The link between immunity, autoimmunity and endometriosis: a literature update 2018
- Molecular Pathology and Therapy of Endometriosis: Revisited 2013
- Possible effects of endometriosis-related immune events on reproductive function 2013
- Endometriosis and Autoimmunity 2011
- Endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:02:47.667321+00:00
License: CC0
· commercial use OK